Product NDC: | 68387-310 |
Proprietary Name: | Ranitidine Hydrochloride |
Non Proprietary Name: | Ranitidine Hydrochloride |
Active Ingredient(s): | 150 mg/1 & nbsp; Ranitidine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68387-310 |
Labeler Name: | Keltman Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074467 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090701 |
Package NDC: | 68387-310-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68387-310-30) |
NDC Code | 68387-310-30 |
Proprietary Name | Ranitidine Hydrochloride |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68387-310-30) |
Product NDC | 68387-310 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ranitidine Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20090701 |
Marketing Category Name | ANDA |
Labeler Name | Keltman Pharmaceuticals Inc. |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |